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OBJECTIVES The goal of this study was to examine mortality associated with tricuspid regurgitation (TR)
after controlling for left ventricular ejection fraction (LVEF), right ventricular (RV) dilation
and dysfunction, and pulmonary artery systolic pressure (PASP).
BACKGROUND Tricuspid regurgitation is a frequent echocardiographic finding; however, the association with
prognosis is unclear.
METHODS We retrospectively identified 5,223 patients (age 66.5  12.8 years; predominantly male)
undergoing echocardiography at one of three Veterans Affairs Medical Center laboratories
over a period of four years. Follow-up data were available for four years (mean 498  402
days). Kaplan-Meier and proportional hazards methods were used to compare differences in
survival among TR grades.
RESULTS Mortality increased with increasing severity of TR. The one-year survival was 91.7% with no
TR, 90.3% with mild TR, 78.9% with moderate TR, and 63.9% with severe TR. Moderate
or greater TR was associated with increased mortality regardless of PASP (hazard ratio [HR]
1.31, 95% confidence interval [CI] 1.16 to 1.49 for PASP 40 mm Hg; HR 1.32, 95% CI
1.05 to 1.62 for PASP 40 mm Hg) and LVEF (HR 1.49, 95% CI 1.34 to 1.66 for EF
50%; HR 1.54, 95% CI 1.37 to 1.71 for EF50%). When adjusted for age, LVEF, inferior
vena cava size, and RV size and function, survival was worse for patients with moderate (HR
1.17, 95% CI 0.96 to 1.42) and severe TR (HR 1.31, 95% CI 1.05 to 1.66) than for those with
no TR.
CONCLUSIONS We conclude that increasing TR severity is associated with worse survival in men regardless
of LVEF or pulmonary artery pressure. Severe TR is associated with a poor prognosis,
independent of age, biventricular systolic function, RV size, and dilation of the inferior vena
cava. (J Am Coll Cardiol 2004;43:405–9) © 2004 by the American College of Cardiology
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mricuspid regurgitation (TR) is a common echocardio-
raphic finding that is present in 80% to 90% of normal
ndividuals (1). Data on mortality in patients with other TR
tiologies and severity are limited. We designed this study
o examine mortality associated with TR after controlling
or left ventricular ejection fraction (LVEF), right ventric-
lar (RV) dilation and dysfunction, and pulmonary artery
ystolic pressure (PASP). We wished to test the hypothesis
hat moderate or greater TR adversely impacts survival,
ndependent of pulmonary artery pressure and LVEF.
ETHODS
atient selection. We evaluated 5,507 consecutive patients
ndergoing echocardiography at one of the three laborato-
ies at the Palo Alto Veterans Affairs Heath Care System
etween August 1998 and July 2002. We excluded 284
atients because the severity of TR was not reported,
esulting in a study sample of 5,223. We identified sub-
roups of patients with normal or high (40 mm Hg)
ASP (2) and patients with normal (50%) or reduced
VEF.
From the *Veterans Affairs Medical Center, Palo Alto; and †University of
alifornia San Francisco, San Francisco, California. Dr. Heidenreich is supported by
Career Development Award from the Veterans Affairs Health Services Research and
evelopment Service.
Manuscript received December 13, 2002; revised manuscript received September 2,P003, accepted September 16, 2003.utcome. Veterans Affairs data and the Social Security
eath Index were used to determine survival after echocar-
iography. Patients not known to have died were censored
t the date of their last clinic or clinical laboratory visit. This
tudy was approved by the Administrative Panel on Human
ubjects in Medical Research at Stanford University.
chocardiographic examination. A complete echocardio-
raphic examination was performed for routine clinical
valuation, including two-dimensional, pulsed-wave,
ontinuous-wave, and color Doppler imaging (Agilent So-
os 5500, 2500, and 1500 ultrasound systems). Continuous-
ave Doppler was used to record flow and regurgitant jet
ignals in the apical four-chamber and RV inflow views.
Right ventricular size and function were qualitatively
raded in the apical four-chamber and subcostal views.
ricuspid regurgitation was graded qualitatively using Fra-
ingham Heart Study criteria (1): mild if the regurgitant jet
rea/right atrial area was19%; moderate if 20% to 40%; or
evere if 41%. Enlargement of the RV was considered
ild if the RV was greater than two-thirds of the LV but
ess than the LV size; moderate if the RV equaled the LV;
nd severe if the RV was greater than the LV (3). Right
entricular systolic function was estimated by the attending
chocardiographer as normal or reduced, using the follow-
ng criteria as a sign of RV dysfunction: 1) any RV wall
otion abnormalities; and 2) descent of base 2.0 cm (4).
atients with moderate and severe RV enlargement were
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nlargement.
Right atrial pressure was estimated by visualizing the
nferior vena cava (IVC) and its response to respiration.
ight atrial pressure was estimated as 5 mm Hg if the IVC
as2.0 cm in diameter at the junction of the right atrium,
5 mm Hg if the IVC was dilated and collapsed with
espiration, and 20 mm Hg if the IVC was dilated and did
ot collapse with respiration. Estimated PASP was calcu-
ated as the sum of tricuspid jet gradient and estimated right
trial pressure (5,6).
tatistical analysis. The software JMP version 3.1 (SAS
nstitute, Cary, North Carolina) was used for statistical
nalysis. A two-sided p value 0.05 was considered signif-
cant. Kaplan-Meier curves using the log-rank test were
enerated to determine the association between the severity
f TR and survival. When groups were compared, analysis
f variance was used for continuous variables, and the
hi-square test was used for categorical variables. Indicators
dummy variables) were assigned to categorical variables
yes/no) for calculation of mortality hazard ratios (HRs),
sing univariate proportional hazards regression analyses.
roportional hazards methods were also used to adjust the
R hazard for RV size and function, LVEF, and age. A
econd analysis was performed that also controlled for
ulmonary artery pressure in those with an adequate TR
ignal. The co-variates were removed stepwise until only
hose significant at p  0.05 remained.
ESULTS
here were 601 patients (11.5%) with no TR, 3,805
68.8%) with mild TR, 620 (11.8%) with moderate TR, and
99 (3.8%) with severe TR. The majority of patients were
ale (98%), and the patients’ mean age was 66.5  12.8 v
IVC  inferior vena cava; LVEF  left ventricular ejection fracears (range 20 to 95). Sixty-four patients had primary
ricuspid valve pathology, 45 had a mildly thickened valve, 7
ad a moderately thickened valve, 8 had an annuloplasty
ing, and 4 had a bioprosthetic valve.
Table 1 shows the characteristics of patients graded by
R severity. Patients with moderate or severe TR were
lder and had worse ventricular function than those with
ess TR.
urvival analysis. A total of 815 (15.6%) patients died
Table 2) during a mean follow-up period of 498  402
ays. The one-year survival rates for patients were
1.7% with no TR, 90.3% with mild TR, 78.9% with
oderate TR, and 63.9% with severe TR (Fig. 1). Univar-
ate analysis indicated that TR, RV dilation, reduced RV
unction, LVEF, pulmonary artery pressure, and IVC dila-
ion were individually associated with higher mortality
Table 2).
Figures 2A and 2B shows the relationship between
everity of TR and mortality for patients with high (40
m Hg) and normal (40 mm Hg) PASP. Patients with
oderate or greater TR had increased mortality compared
ith those with mild or less TR, irrespective of PASP (HR
.31, 95% confidence interval [CI] 1.16 to 1.49 for PASP
40 mm Hg; HR 1.32, 95% CI 1.05 to 1.62 for PASP40
m Hg).
Mortality also increased with increasing severity of TR
n patients with a low EF (50%) and normal EF
Figs. 3A and 3B). Moderate or greater TR was associated
ith increased mortality, regardless of LVEF (HR 1.49,
5% CI 1.34 to 1.66 for EF 50%; HR 1.54, 95% CI 1.37
o 1.71 for EF 50%), when compared with mild or less
R.
Moreover, the proportional hazards method showed that
atients with moderate (HR 1.17, 95% CI 0.96 to 1.42) and
evere TR (HR 1.31, 95% CI 1.05 to 1.66) had a worse
rognosis than those with no TR after adjustment for age,
VEF, IVC size, RV size, and RV function (Table 3). In a
ubset of patients with TR and measured pulmonary artery
ressure, only TR (severe vs. mild: HR 1.23, 95% CI 1.03
o 1.47; moderate vs. mild: HR 1.08, 95% CI 0.95 to 1.23),
ulmonary artery pressure and age were associated with
ncreased mortality. The results were not significantly
hanged by excluding patients with abnormal tricuspid
orphology (n  52) or an annuloplasty ring/bioprostheticAbbreviations and Acronyms
HR  hazard ratio
IVC  inferior vena cava
LV  left ventricle/ventricular
LVEF  left ventricular ejection fraction
PASP  pulmonary artery systolic pressure
RV  right ventricle/ventricular
TR  tricuspid regurgitationalve (n  12).Table 1. Clinical and Echocardiographic Features of Patients With Tricuspid Regurgitation
No TR
(n  600)
Mild TR
(n  3,804)
Moderate TR
(n  620)
Severe TR
(n  199) p Value
Age (yrs) 62.2  12.8 66.0  12.6 71.9  11.7 71.9  12.4  0.0001
LVEF (%) 57.3  9.1 55.4  11.6 47.1  15.6 40.4  17.2  0.0001
RV dilation 8% 11% 35% 66%  0.0001
RV dysfunction 3% 8% 30% 61%  0.0001
Dilated IVC 6% 11% 44% 76%  0.0001
Data are presented as the mean value  SD or percentage of patients.
tion; RV  right ventricular; TR  tricuspid regurgitation.
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February 4, 2004:405–9 Tricuspid Regurgitation and Long-Term SurvivalISCUSSION
ricuspid regurgitation is a common echocardiographic
nding (1) that is often considered benign unless associated
ith significant pulmonary hypertension or RV or LV
ysfunction (7,8). Our study confirms that mild or less TR
oes not affect the outcome.
However, moderate or greater TR was associated with a
orse prognosis, even in the absence of ventricular dysfunc-
Table 2. Mortality Versus Echocardiographic F
Analysis
Variable n Dea
TR
None 600 6
Mild 3,804 49
Moderate 620 17
Severe 199 8
RV enlargement
None 4,408 61
Mild 665 14
Moderate and severe 144 6
RV dysfunction
None 4,596 62
Present 614 19
IVC dilation
None 3,350 38
Dilated 519 12
Dilated (without collapse) 184 7
PASP*
40 mm Hg 1,360 13
40 mm Hg 935 26
Ejection fraction
50% 3,901 49
50% 1,306 31
*Pulmonary artery systolic pressure (PASP) was available in
CI  confidence interval; other abbreviations as in Table
igure 1. Kaplan-Meier survival curves for all patients with tricuspid
egurgitation (TR). Survival is significantly worse in patients with moder-Lte and severe TR.ion or pulmonary hypertension. Identification of risk fac-
ors for death is important for guidance of therapy, assign-
ent of health care resources, and counseling of patients.
oth decreased LV systolic function and elevated PASP are
ell-known markers of decreased survival (9). Because
ulmonary hypertension and LV dysfunction, through sec-
ndary RV failure, may cause TR, we evaluated separate
atient cohorts with normal and high PASP and normal
nd low LVEF. We found that patients with moderate or
reater TR have worse survival than patients with mild or
ess TR, regardless of pulmonary artery pressure and LVEF.
ased on these findings, significant (moderate or greater)
R should be considered an additional risk factor for
ortality.
Previous studies have shown that an enlarged RV is
ssociated with increased mortality (10). Our findings show
hat increasing grades of TR are commonly associated with
V dilation and dysfunction and elevated right atrial pres-
ure, as measured by IVC dilation. However, RV and atrial
bnormalities only partially explain the association between
oderate or greater TR and mortality observed in our study.
The reason for higher mortality with significant TR
emains to be determined. It is possible that TR is a more
ensitive marker of RV dysfunction than is visual interpre-
ation of systolic performance. Also, the presence of TR
ay mask the decreased contractility of the RV, analogous
o the effect of mitral regurgitation on the ability to estimate
ngs by Univariable Proportional Hazards
%) Hazard Ratio (95% CI) p Value
) 1.0
) 1.12 (0.98–1.28) 0.09
) 1.67 (1.45–1.94)  0.0001
) 2.20 (1.83–2.55)  0.0001
) 1.0
) 1.29 (1.12–1.41)  0.0001
) 1.94 (1.69–2.20)  0.0001
) 1.0
) 1.62 (1.49–1.75)  0.0001
) 1.0
) 1.54 (1.39–1.70)  0.0001
) 2.09 (1.85–2.36)  0.0001
) 1.0
) 1.82 (1.65–2.02)  0.0001
) 1.0
) 1.42 (1.32–1.52)  0.0001
ts with an adequate tricuspid regurgitation (TR) envelope.indi
ths (
1 (10
9 (13
1 (28
4 (42
0 (14
3 (22
2 (43
3 (14
0 (31
9 (12
5 (24
7 (42
6 (10
5 (28
6 (13
4 (24
patien
1.V contractility from LVEF. Future studies should exam-
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Tricuspid Regurgitation and Long-Term Survival February 4, 2004:405–9ne the cause of death in patients with significant TR to
etter determine the reason for the association of TR with
ortality.
tudy limitations. Most of the patients were men, and
hese data may not be applicable to female patients. The
riteria for quantification of TR are largely subjective, and
uantitative analysis of TR using proximal isovelocity sur-
ace area and jet width methods (11) may have been helpful.
linical characteristics, including the patients’ functional
lass and the effect of specific treatments, were unknown at
he time of echocardiography. Finally, the causes of death
ere not identified. Median follow-up was 428 days; how-
ver, follow-up was available for 584 patients for more than
hree years. In addition, interobserver variability is unknown
nd, if substantial, would make it difficult to detect differ-
nces in outcome between patients groups. We relied on the
resence of an adequate TR envelope to estimate pulmonary
rtery pressure.
onclusions. We conclude that increasing TR severity is
igure 2. Kaplan-Meier survival curves for (A) patients with tricuspid
egurgitation (TR) and high pulmonary artery systolic pressure (40 mm
g) and (B) patients with TR and normal pulmonary artery systolic
ressure (40 mm Hg).ssociated with worse survival in men regardless of LVEF orulmonary artery pressure. Severe TR is associated with a
oor prognosis, independent of age, biventricular systolic
unction, RV size, and IVC dilation. Further studies are
eeded to better determine the mechanism responsible for
he association between TR and increased mortality.
igure 3. Kaplan-Meier survival curve for (A) patients with tricuspid
egurgitation (TR) and a low left ventricular ejection fraction (50%) and
B) patients with TR and a normal left ventricular ejection fraction
50%).
able 3. Clinical and Echocardiographic Parameters Associated
ith Long-Term Survival*
Variable Chi-Square p Value
R
Mild 0.15 0.70
Moderate 2.65 0.10
Severe 5.79 0.02
ge 65.75  0.0001
VEF 4.28 0.04
VC
Dilated 13.95 0.0002
Dilated without collapse 21.15  0.0001
V enlargement
Mild 0.90 0.34
Moderate and severe 4.05 0.04
V dysfunction 2.12 0.14
Using a proportional hazards model.
Abbreviations as in Table 1.
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